Related Experiment Video
Updated: Jul 10, 2026

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix
Published on: October 20, 2021
[Comparative study on dendritic cells stimulated with HBsAg or HBcAg in patients with chronic hepatitis B]
Peng Kang1, Shu-Lan Luo, Shu-Chen Li
1Department of Infectious Diseases, The Second Affiliated Hospital, Harbin Medical University, Harbin, China.
Insights
Hepatitis B core antigen (HBcAg) more effectively activates dendritic cells (DCs) than hepatitis B surface antigen (HBsAg). This enhanced DC activation by HBcAg leads to a stronger T cell immune response in chronic hepatitis B patients.
Area of Science:
- Immunology
- Hepatology
- Cell Biology
Background:
- Chronic hepatitis B (CHB) is a significant global health concern.
- Dendritic cells (DCs) play a crucial role in initiating adaptive immune responses.
- Understanding DC activation by hepatitis B virus (HBV) antigens is key to developing effective immunotherapies.
Purpose of the Study:
- To investigate the differential activation of dendritic cells (DCs) by hepatitis B core antigen (HBcAg) and hepatitis B surface antigen (HBsAg) in patients with chronic hepatitis B.
- To evaluate the impact of antigen stimulation on DC maturation markers, T lymphocyte proliferation, and interleukin-12 production.
Main Methods:
- Dendritic cells were isolated from peripheral blood monocytes of CHB patients.
- DCs were stimulated with either HBsAg or HBcAg.
- Flow cytometry was used to analyze DC surface molecule expression (CD86).
- T lymphocyte proliferation was assessed using a liquid scintillation counter.
- Interleukin-12 (IL-12) levels in mixed lymphocyte reactions (MLRs) were measured by ELISA.
Main Results:
- HBeAg stimulation significantly increased the expression rate of the DC activation marker CD86 compared to HBsAg stimulation and controls.
- DCs loaded with HBcAg demonstrated a significantly higher capacity to induce T lymphocyte proliferation than those loaded with HBsAg.
- The production of IL-12 in MLRs was significantly elevated when DCs were stimulated with HBcAg compared to HBsAg.
Conclusions:
- Hepatitis B core antigen (HBcAg) is a more potent stimulator of dendritic cell activation compared to hepatitis B surface antigen (HBsAg) in the context of chronic hepatitis B.
- HBcAg-stimulated DCs exhibit enhanced antigen-presenting capabilities, leading to a more robust specific T cell immune response.
- These findings suggest that HBcAg may hold therapeutic potential for enhancing immune responses against chronic hepatitis B.
Objective:
To study activation of dendritic cells (DC) isolated from peripheral blood monocytes of patients with chronic hepatitis B after stimulation with HBsAg or HBcAg.
Methods:
DCs were isolated from peripheral blood monocytes of patients with chronic hepatitis B. DCs were impulsed with HBsAg and HBcAg separately before their maturation. The expression levels of DC surface molecule were analyzed by using flow cytometry and the ability of DC to induce T lymphocyte proliferation was evaluated by a liquid scintillation counter and the amount of interleukin-12 (IL-12) in mixed lymphocytic (IL-12) in mixed lymphocytic reaction (MLR) was measured by using ELISA.
Results:
The expression rate of CD86 significantly increased to (29.20 +/- 5.18)% on DC after loading with HBcAg as compared with those after loading with HBsAg (76.19 +/- 3.90)% and controls (62.37 +/- 4.24)%, P>0.01. The ability of DC after loading with HBcAg to induce T lymphocyte proliferation (34,326 +/- 3088 cpm) was significantly higher than that of DC after loading with HBsAg (20,306 +/- 2897 cpm) and controls (3454 +/- 409 cpm), P greater than 0.01. The amount of IL-12 in MLR of DC after loading with HBcAg was (348 +/- 42.8) ng/L, which was significantly higher than those of DC after loading with HBsAg (226 +/- 30.6) ng/L and controls (116 +/- 15.6) ng/L, P greater than 0.01.
Conclusion:
Human dendritic cell stimulated with HBcAg could more efficiently present antigen and induce specific T cell immune response.
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction
